Susana Vives-Polo

8PUBLICATIONS
51CO-AUTHORS
Gene expression (incl. microarray and other genome-wide approaches)Medical infection agents (incl. prions)Respiratory diseasesHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Oct 14, 2026
Rapid molecular screening of adult AML: Experience from the Spanish CETLAM cooperative group.

|Aug 31, 2026
Real-World Outcomes of Midostaurin Plus Intensive Chemotherapy in FLT3-Mutated AML: The PETHRATIFY Study.

|Jan 03, 2025
Treatment patterns and outcomes in secondary acute myeloid leukemia arising after hypomethylating agents: PETHEMA registry study.

Pilar Lloret-Madrid, Blanca Boluda, Joaquín Martínez-López

|Dec 17, 2024
Salvage Therapy with Second-Generation Inhibitors for FLT3 Mutated Acute Myeloid Leukemia: A Real-World Study by the CETLAM and PETHEMA Groups.

Susana Vives, David Quintela, Mireia Morgades

|Oct 30, 2024
A phase 2, multicenter, clinical trial of CPX-351 in older patients with secondary or high-risk acute myeloid leukemia: PETHEMA-LAMVYX.

Eduardo Rodríguez-Arbolí, Rebeca Rodríguez-Veiga, Elena Soria-Saldise

|Jun 19, 2024
Evolving patterns and clinical outcome of genetic studies performed at diagnosis in acute myeloid leukemia patients: Real life data from the PETHEMA Registry.

Jorge Labrador, David Martínez-Cuadrón, Blanca Boluda

Pageof 2

Frequent Collaborators

5 joint publications

Pau Montesinos

4 joint publications

Mar Tormo

4 joint publications

Jorge Labrador Gómez

3 joint publications

Eduardo Rodríguez-Arbolí